Home » Erasmus to Use Illumina's 610-Quad BeadChips in Fetal Abnormality Study

Erasmus to Use Illumina's 610-Quad BeadChips in Fetal Abnormality Study

Jan 23, 2008
NEW YORK (GenomeWeb News) — The Erasmus Medical Center will use Illumina’s BeadChips in a 10,000-subject study aimed at identifying early environmental and genetic causes of abnormal growth in fetal development, Illumina said today.
 
The Rotterdam, Netherlands-based research hospital has bought Illumina’s Infinium HD Human610-Quad BeadChips for the Generation R Study, which is backed in part by the Dutch government, industry partners, and the hospital.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.